Yes, hepatitis C can be cured with antiviral medication, and most people who treat it clear the virus completely

Modern hepatitis C treatment works. Between 95 and 99 percent of people who take the right medication for 8 to 12 weeks will have an undetectable viral load—meaning the virus is gone and cannot spread to others. This is a cure, not management. The virus does not come back once cleared, though you can catch hepatitis C again if exposed to infected blood.

The medications that make this possible are called direct-acting antivirals (DAAs). They target the hepatitis C virus directly and stop it from reproducing. The most commonly prescribed regimen is sofosbuvir combined with another drug like velpatasvir or ledipasvir, taken as a single daily pill. Treatment length and which specific combination your doctor chooses depends on your hepatitis C genotype (the strain you have) and whether your liver already has scarring.

The main barrier to cure is not whether treatment works—it does—but whether people know they have hepatitis C and can access the medication. Many people carry the virus without symptoms for years. Testing is the first step, and treatment is the second.

Key Takeaways

  • Direct-acting antiviral medications cure hepatitis C in 95 to 99 percent of cases over 8 to 12 weeks of daily pills.
  • Your doctor will test your hepatitis C genotype and check for liver scarring to decide which medication and how long you need to take it.
  • Once the virus is undetectable, you cannot transmit it to others, though reinfection is possible if you are exposed to infected blood again.
  • Treatment works regardless of how long you have had hepatitis C or how much liver damage has already occurred.
  • Cost and insurance coverage vary, but many states have programs that cover treatment for people without insurance or with limited income.

How modern antiviral drugs work

Hepatitis C virus needs specific proteins to copy itself and spread through your liver. Direct-acting antivirals block those proteins. Without them, the virus cannot replicate, and your immune system clears what remains. The drugs do not kill the virus directly—they stop it from making new copies of itself.

Different DAAs target different viral proteins. Sofosbuvir blocks the enzyme that copies the viral genome. Velpatasvir blocks the protein that assembles new virus particles. Ledipasvir blocks another step in the replication process. Combining drugs that work on different targets makes it nearly impossible for the virus to develop resistance, which is why combination therapy is standard.

The reason cure rates are so high is that hepatitis C virus mutates slowly compared to other viruses like HIV or influenza. Once you stop the replication with DAAs, the virus has little chance to evolve around the drugs. Your body then clears the remaining virus naturally.

Treatment length and genotype matter

Hepatitis C has six main genotypes, numbered 1 through 6. Genotype 1 is most common in North America and Europe. Genotype 3 is common in Asia and among people who inject drugs. Your genotype determines which DAA combination works best and how long you need to take it.

For genotype 1, the standard regimen is sofosbuvir plus velpatasvir, taken once daily for 12 weeks. For genotype 3, the same combination may require 12 weeks, or sofosbuvir plus velpatasvir plus voxilaprevir for 12 weeks if your liver already has cirrhosis. Genotypes 2, 4, 5, and 6 typically respond to sofosbuvir plus velpatasvir for 12 weeks as well. Your doctor will order a genotype test before starting treatment to prescribe the right regimen.

If your liver has advanced scarring (cirrhosis), treatment may take longer or require a different drug combination. This is why your doctor will also check your liver function and degree of scarring before deciding on your exact treatment plan.

What happens during and after treatment

You take one pill by mouth once daily, usually with food. Most people tolerate DAAs well. Side effects are generally mild—fatigue, headache, or nausea—and less common than with older hepatitis C treatments. You will have blood tests at the start of treatment, at week 4, and at the end of the 8- to 12-week course to confirm the virus is undetectable.

After you finish the medication, your doctor will test you again 12 weeks later to confirm the virus remains undetectable. This is called a sustained virologic response (SVR). If your viral load is undetectable at that 12-week mark, you are cured. The virus will not return.

Once cured, you cannot transmit hepatitis C to others through sexual contact, sharing food, or casual contact. You can only transmit it through direct blood-to-blood contact—sharing needles, for example, or during childbirth if you have a very high viral load. If you have scarring from hepatitis C (cirrhosis), that scarring does not reverse, but it stops getting worse once the virus is gone.

Who can receive treatment

In most countries, anyone with hepatitis C can receive DAA treatment. There are no absolute medical reasons to deny treatment. People with HIV and hepatitis C together can be treated—DAAs work in coinfected people, though some drug interactions require monitoring. People with advanced liver disease or cirrhosis can be treated and should be, because clearing the virus stops further damage.

The main barriers are practical, not medical. You need a doctor to prescribe the medication, which means access to healthcare. You need insurance or the ability to pay, though costs have dropped significantly since DAAs were introduced. You need to be able to take a daily pill for 8 to 12 weeks, which is straightforward for most people but may be difficult if you are homeless, in active addiction, or in an unstable situation.

Some states and countries have restrictions on who can receive treatment through public programs—for example, requiring abstinence from alcohol or drugs, or limiting treatment to people with advanced liver disease. These restrictions vary widely and are changing. If you are told you cannot receive treatment, ask whether private insurance, a patient assistance program, or a different public program might cover it.

Cost and how to pay for treatment

A full course of DAA treatment costs between $24,000 and $84,000 before insurance, depending on the specific drugs and length of treatment. With insurance, your out-of-pocket cost depends on your plan—it may be nothing, or it may be a copay of a few hundred dollars.

If you do not have insurance, several options exist. Many pharmaceutical companies offer patient assistance programs that provide medication free or at reduced cost if your income is below a certain threshold. Gilead Sciences (which makes sofosbuvir and velpatasvir) and AbbVie (which makes other DAA combinations) both have these programs. Your doctor's office can help you apply.

Some state Medicaid programs cover hepatitis C treatment for all adults. Others restrict it to people with advanced liver disease or cirrhosis, though these restrictions are loosening. Your state health department or a local hepatitis C organization can tell you what your state covers. The National Hepatitis C Program and local harm reduction organizations also help people find treatment regardless of insurance status.

Testing and diagnosis before treatment

Before you can be treated, you need to know you have hepatitis C. The first test is an antibody test, which shows whether you have ever been exposed to the virus. If that is positive, a second test called an HCV RNA test (or viral load test) confirms whether you currently have the virus. Some people clear hepatitis C on their own and test positive for antibodies but negative for RNA—they do not need treatment because they are already cured.

If your RNA test is positive, your doctor will order a genotype test to identify which strain you have, and usually a test to check your liver function and degree of scarring. This might be a blood test called FibroTest or FibroScan, or an ultrasound. These tests take a few weeks total, but they tell your doctor exactly what treatment you need.

You can get hepatitis C testing at your primary care doctor, at a hepatitis C clinic, at a sexual health clinic, or at harm reduction programs if you inject drugs. If you do not have a doctor, your local health department can direct you to a testing site.

What happens if you do not treat hepatitis C

Hepatitis C causes inflammation in the liver over years or decades. In some people, this leads to cirrhosis (severe scarring) and liver failure. In others, it progresses slowly or not at all. You cannot predict which course you will take based on symptoms alone—many people have no symptoms for 20 or 30 years, then develop cirrhosis.

If cirrhosis develops, the risk of liver cancer increases. Cirrhosis also causes portal hypertension, which can lead to bleeding in the esophagus, fluid buildup in the abdomen, and kidney failure. These are serious complications that require ongoing monitoring and treatment.

The reason to treat hepatitis C is not urgency—the virus moves slowly—but certainty. Treatment cures the disease and stops all of these complications from developing. Once cured, your liver stops being damaged by the virus, even if scarring already exists.

Frequently Asked Questions

Can you catch hepatitis C twice?

Yes. Once you are cured, you have no immunity to hepatitis C, so reinfection is possible if you are exposed to infected blood again. This is most common among people who inject drugs and share needles. If you are reinfected, the new infection can be treated the same way as the first one.

Does hepatitis C treatment work if your liver already has cirrhosis?

Yes. Treatment cures hepatitis C even in people with advanced cirrhosis. The scarring does not reverse, but stopping the virus prevents further damage and reduces the risk of liver cancer and liver failure. People with cirrhosis should be treated.

What if you miss doses of the medication?

Missing occasional doses usually does not prevent cure, but missing many doses or stopping early can allow the virus to continue replicating and may lead to treatment failure. Take the medication as prescribed. If you are having trouble taking it daily, tell your doctor—they may be able to help or adjust your plan.

Can you drink alcohol while taking hepatitis C treatment?

The medication itself does not interact with alcohol, but alcohol damages the liver and can worsen hepatitis C. Most doctors recommend avoiding alcohol during treatment and after cure if you have cirrhosis. If you drink heavily, talk to your doctor about support to reduce or stop drinking.

How long after treatment ends do you know if you are cured?

Your doctor will test your viral load 12 weeks after you finish the medication. If it is undetectable at that point, you are cured. Some doctors test again at 24 weeks to be certain, but 12 weeks is the standard definition of cure.